Michael Fink

External Validation of the United Kingdom Transplant Benefit Score in Australia and New Zealand

Eunice G Lee, Marcos V Perini, Enes Makalic, Gabriel C Oniscu, Michael A Fink

Journal article  |  2022  |  PROGRESS IN TRANSPLANTATION

Introduction: In Australia and New Zealand, liver allocation is needs based (based on model for end-stage liver disease score). An..

Monitoring quality of care in hepatocellular carcinoma: A modified Delphi consensus

Ashika D Maharaj, John Lubel, Eileen Lam, Paul J Clark, Oliver Duncan, Jacob George, Gary P Jeffrey, Lara Lipton, Howard Liu, Geoffrey McCaughan, Eu-Ling Neo, Jennifer Philip, Simone Strasser, Katherine Stuart, Alexander Thompson, Jonathan Tibballs, Thomas Tu, Michael C Wallace, Alan Wigg, Marnie Wood, et al.

Journal article  |  2022  |  HEPATOLOGY COMMUNICATIONS

Although there are several established international guidelines on the management of hepatocellular carcinoma (HCC), there is limi..

The Hidden Epidemic: The Prevalence and Impact of Concurrent Liver Diseases in Patients Undergoing Liver Transplantation in Australia and New Zealand

Jess Howell, Avik Majumdar, Michael Fink, Mandy Byrne, Geoff McCaughan, Simone I Strasser, Michael Crawford, Peter Hodgkinson, Katherine A Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C Wallace, Ed Gane, Alex Thompson, Paul Gow

Journal article  |  2022  |  TRANSPLANTATION DIRECT

Background. Prevalence of concurrent liver diseases among liver transplant recipients and impact on posttransplant outcomes are un..

Expansion of Liver Transplantation Criteria for Hepatocellular Carcinoma from Milan to UCSF in Australia and New Zealand and Justification for Metroticket 2.0.

Savio G Barreto, Simone I Strasser, Geoffrey W McCaughan, Michael A Fink, Robert Jones, John McCall, Stephen Munn, Graeme A Macdonald, Peter Hodgkinson, Gary P Jeffrey, Bryon Jaques, Michael Crawford, Mark E Brooke-Smith, John W Chen

Journal article  |  2022  |  Cancers (Basel)

Background: Expansion in liver transplantation (LT) criteria for HCC from Milan to UCSF has not adversely impacted overall surviva..

Quantification of Graft-Derived Cell-Free DNA during Normothermic Machine Perfusion in Liver Transplantation Is Feasible and May Be a Useful Future Tool for Assessing Organ Health

DRA Cox, E Lee, B Wong, M Fink, R Jones, A Dobrovic, A Testro, MV Perini, G Starkey, V Muralidharan

Journal article  |  2022  |  HPB

Procurement-related liver injury for transplantation: an analysis of the risk factors and consequences in an Australian transplant centre

James Walcott, Michael Fink, Isaac Ealing, Christopher Christophi, Vijayaragavan Muralidharan

Journal article  |  2021  |  ANZ JOURNAL OF SURGERY

BACKGROUND: Liver transplantation is an established treatment for liver failure, and its success relies on the quality of the dona..

Prenatal diagnosis of rhombencephalosynapsis: neuroimaging features and severity of vermian anomaly

K Krajden Haratz, P Oliveira Szejnfeld, M Govindaswamy, Z Leibovitz, L Gindes, M Severino, A Rossi, D Paladini, R Garcia Rodriguez, L Ben-Sira, T Borkowski Tillman, R Gupta, G Lotem, N Raz, TENK Hamamoto, D Kidron, A Arad, R Birnbaum, M Brussilov, L Pomar, et al.

Journal article  |  2021  |  ULTRASOUND IN OBSTETRICS & GYNECOLOGY

OBJECTIVES: To describe the prenatal neuroimaging spectrum of rhombencephalosynapsis (RES) and criteria for its classification acc..

Predicting recurrence of hepatocellular carcinoma after liver transplantation using a novel model that incorporates tumor and donor-related factors.

Lorenzo A Orci, Christophe Combescure, Michael Fink, Graziano Oldani, Philippe Compagnon, Axel Andres, Thierry Berney, Christian Toso

Journal article  |  2021  |  Transpl Int

Evidence suggests that liver graft quality impacts on posttransplant recurrence of hepatocellular carcinoma (HCC). As of today, se..

Turning the Tide on Hepatitis C Virus-Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand

Jess Howell, Avik Majumdar, Michael A Fink, Mandy Byrne, Geoff McCaughan, Simone Strasser, Michael Crawford, Peter Hodgkinson, Katherine A Stuart, Caroline Tallis, John Chen, Alan Wigg, Robert Jones, Bryon Jaques, Gary Jeffrey, Leon Adams, Michael C Wallace, Stephen Munn, Ed Gane, Alex J Thompson, et al.

Journal article  |  2021  |  LIVER TRANSPLANTATION

Introduction of universal access to direct-acting antiviral (DAA) therapy for hepatitis C virus (HCV) in Australia and New Zealand..

Clinical outcomes of patients with two small hepatocellular carcinomas

Duy Pham Anh, Karl Vaz, Zaid S Ardalan, Marie Sinclair, Ross Apostolov, Sarah Gardner, Ammar Majeed, Gauri Mishra, Ning Mao Kam, Kurvi Patwala, Numan Kutaiba, Niranjan Arachchi, Sally Bell, Anouk T Dev, John S Lubel, Amanda J Nicoll, Siddharth Sood, William Kemp, Stuart K Roberts, Michael Fink, et al.

Journal article  |  2021  |  WORLD JOURNAL OF HEPATOLOGY

BACKGROUND: Management of single small hepatocellular carcinoma (HCC) is straightforward with curative outcomes achieved by locore..